OR WAIT null SECS
The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.
May 06, 2025
Article
This analysis highlighted the cardiovascular safety of systemic psoriasis drugs using a prospective cohort trial design.
May 05, 2025
These post-hoc analysis findings align with POETYK PSO-4 regarding deucravacitinib’s effectiveness in patients with psoriasis.
This analysis suggests intake of riboflavin, also known as vitamin B2, shows an association with patients’ risk of developing psoriasis.
May 03, 2025
Stay updated with the latest healthcare breakthroughs, including FDA approvals and innovative treatments, in this week's essential news roundup for professionals.
May 02, 2025
These results highlight the association between nail psoriasis and various factors such as male sex and smoking.
May 01, 2025
In this analysis, investigators highlighted both the efficacy and safety regardless of previous utilization of biologic therapies.
April 24, 2025
In this analysis, investigators compared older and younger patients with psoriasis in terms of drug survival and other results of biologic medications.
These data highlight the risk level among certain patients with psoriasis of excessive sun exposure, associated commonly with tanning.
The program can indicate the severity of nail psoriasis and allow practitioners to quickly and accurately diagnose patients.
April 23, 2025
In these findings, the FamilyPso tool was validated for assessing psoriasis burdens on family members in multiple countries.